製品GE10600002は現在お客様の国では販売されていません。 製品に関するお問い合わせはこちら（テクニカルサービス）
おすすめの製品
包装
pkg of 1 ea
メーカー／製品名
Cytiva 10600002
ロールW × L
300 mm × 4 m
ポアサイズ
0.45 μm pore size
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
詳細
Amersham Protran 0.45 NC is a nitrocellulose membrane with a 0.45 µm pore size for use in Western blot protocols. Amersham Protran nitrocellulose membranes offer excellent sensitivity, resolution, and low background noise, especially when used with Amersham ECL, Amersham ECL Prime, or Amersham ECL Select Western Blotting detection reagents. Protran NC membranes are available in popular precut sizes for a wide range of laboratory applications. This product was formerly called Protran BA85.
アプリケーション
Amersham™ Protran® Western blotting membranes, nitrocellulose is suitable for use in:
- Western blotting
- Southern blotting
- Northern blotting
特徴および利点
- Low background and excellent signal-to-noise ratios
- Compatible with a variety of labelling and detection systems
- High binding capacity
- Suitable for proteins with a wide range of molecular weights
- Ideal tool for your antibody purification and analysis workflow
- Proprietary nitrocellulose formula ensures a long shelf life of bound proteins
保管および安定性
Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
法的情報
Amersham is a trademark of Cytiva
Protran is a registered trademark of Cytiva
保管分類コード
4.1B - Flammable solid hazardous materials
最新バージョンのいずれかを選択してください：
Emilia A H Vanni et al.
PLoS pathogens, 16(12), e1009166-e1009166 (2020-12-29)
Herpes simplex virus 1 (HSV-1) infects skin and mucosal epithelial cells and then travels along axons to establish latency in the neurones of sensory ganglia. Although viral gene expression is restricted during latency, the latency-associated transcript (LAT) locus encodes many
Marianna Lucafò et al.
Cancer chemotherapy and pharmacology, 86(3), 361-374 (2020-08-11)
Glucocorticoids (GCs) are commonly used as therapeutic agents for immune-mediated diseases and leukemia. However, considerable inter-individual differences in efficacy have been reported. Several reports indicate that the inhibitor of mTOR rapamycin can reverse GC resistance, but the molecular mechanism involved
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）
